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Coagulase negative staphylococci (CoNS) and Listeria monocytogenes have important
roles in pathogenesis of various genital tract infections and fatal foetomaternal infections,
respectively. The aim of our study was to investigate the inhibitory effects of two novel bac-
teriocins on biofilms of CoNS and L. monocytogenes genital isolates.
Methods
The effects of licheniocin 50.2 from Bacillus licheniformis VPS50.2 and crude extract of
bacteriocins produced by Lactococcus lactis subsp. lactis biovar. diacetylactis BGBU1-4
(BGBU1-4 crude extract) were evaluated on biofilm formation and formed biofilms of eight
CoNS (four S. epidermidis, two S. hominis, one S. lugdunensis and one S. haemolyticus)
and 12 L. monocytogenes genital isolates.
Results
Licheniocin 50.2 and BGBU1-4 crude extract inhibited the growth of both CoNS and L.
monocytogenes isolates, with MIC values in the range between 200–400 AU/ml for lichenio-
cin 50.2 and 400–3200 AU/ml for BGBU1-4 crude extract. Subinhibitory concentrations
(1/2 × and 1/4 ×MIC) of licheniocin 50.2 inhibited biofilm formation by all CoNS isolates
(p < 0.05, respectively), while BGBU1-4 crude extract inhibited biofilm formation by all
L. monocytogenes isolates (p < 0.01 and p < 0.05, respectively). Both bacteriocins in
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concentrations of 100 AU/mL and 200 AU/mL reduced the amount of 24 h old CoNS and L.
monocytogenes biofilms (p < 0.05, p < 0.01, p < 0.001).
Conclusions
This study suggests that novel bacteriocins have potential to be used for genital application,
to prevent biofilm formation and/or to eradicate formed biofilms, and consequently reduce
genital and neonatal infections by CoNS and L. monocytogenes.
Introduction
Coagulase negative staphylococci (CoNS) and Listeria monocytogenes are widely involved in
minor to severe human infections, especially in immunocompromised patients. Despite their
lower virulence, CoNS are well adapted to form strong biofilms and more recently, it has been
noted that their biofilms have also an important role in pathogenesis of various genital tract
infections, such as aerobic vaginitis and persistent nonspecific urethritis [1,2]. L. monocyto-
genes can colonise and live inside biofilms in the genital tract of women [3]. Although the inci-
dence of L. monocytogenes in the vagina may be low [4], the consequences can be devastating,
mostly in pregnancy. This bacterium could be transmitted to the neonate by ascending to the
uterus or during passage of the foetus through the vagina and may cause significant morbidity
and mortality in the neonates [3].
Biofilm is an assemblage of microorganisms embedded in an extracellular polymeric sub-
stance irreversibly attached to abiotic and/or biotic surfaces. Bacteria organized in multilayer
structures differ in their phenotypic and genotypic features from their planktonic counter-
parts. Furthermore, biofilms also provide an ideal niche for the exchange of genes responsible
for antimicrobial resistance [5,6]. According to present knowledge, more than 99% of bacteria
in nature live in biofilms and in 80% of the human infections biofilms are shown to play an
important role [7]. Therefore, biofilm-related infections are a therapeutic challenge of modern
medicine.
Increasing antimicrobial resistance influenced enhanced interest in bacteriocins as alterna-
tive therapeutic means for treating infections. Bacteriocins are defined as antimicrobial pep-
tides or proteins that usually act against closely related or non-related strains to bacteria that
produced them [8,9].
Many recent studies have indicated possible practical applications of bacteriocins in food
technology, but also in pharmacy and clinical medicine [10]. Interestingly, bacteriocins activity
against Neisseria gonorrhoeae [11] and Giardia lamblia [12] was shown pointing to the bacteri-
ocins as promising antimicrobial candidates for treatment of different pathogens. Further-
more, bacteriocins can inhibit growth of multiresistant pathogens of great importance, such as
methicilin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus spp. [13].
The antibiofilm activity of various bacteriocins has recently been reported, but the greatest
flaw of these investigations was that most of them were laboratory based studies, i.e. well-
defined reference strains of microorganisms were used for testing [14], but not clinical
isolates.
The aims of the present study were to investigate the effects of subinhibitory concentrations
of bacteriocin licheniocin 50.2 and bacteriocins from Lactococcus lactis subsp. lactis biovar.
diacetylactis BGBU1-4 on biofilm formation by clinical isolates of CoNS and L. monocytogenes
and their antibiofilm activity on formed biofilms.
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Materials and Methods
Purification and biochemical characterisation of bacteriocins
Purification and biochemical characterisation of bacteriocin licheniocin 50.2 from Bacillus
licheniformis VPS50.2 was performed as previously described [15]. Crude extract of bacteri-
ocins produced by Lactococcus lactis subsp. lactis biovar. diacetylactis BGBU1-4 (BGBU1-4
crude extract) was purified from cell-free supernatant of 16 h old overnight culture which
was submitted to precipitation with ammonium sulfate to obtain 20, 30, 40, 50, and 60% of
saturation. The resulting pellets were resuspended in 100 mM sodium phosphate buffer, pH
7 and tested for antimicrobial activity. The most potent fraction, 40% of saturation was sub-
mitted to further purification by chloroform extraction as follows. Equal volumes of resus-
pended pellet and chloroform were vigorously shaken for 15 min, left at +4˚C for one hour
and phases were divided by centrifugation at 13000rpm for 40 min. Obtained interphase
was collected and dried in rotary vacuum evaporator (Eppendorf Concentrator 5301;
Eppendorf). Dried interphase was resuspended in 100 mM sodium phosphate buffer, pH 7
and tested for bacteriocin activity against different indicator strains (L. lactis subsp. lactis
BGMN1-596 [16], L. lactis subsp. cremoris NS1, Lactobacillus paracasei subsp. paracasei
BGHN14 [17], Lactobacillus plantarum A112, Listeria monocytogenes ATCC 19111 and
man-PTS deletion mutant of L. lactis subsp. lactis IL1403 (strain B464) [18]). Biochemical
characterisation of BGBU1-4 and licheniocin 50.2 crude extracts was performed in order to
determine pH range, influence of different temperatures (50˚C, 60˚C, 70˚C, 80˚C, 90˚C and
100˚C) and protelytic enzymes (protease, trypsin, chymotrypsin and pepsin) on bacterio-
cins activity.
Bacterial isolates and growth conditions
In the present study, 8 strains of CoNS (4 strains of Staphylococcus epidermidis, 2 strains of
Staphylococcus hominis, 1 strain of Staphylococcus lugdunensis and 1 strain of Staphylococcus
haemolyticus) isolated from urethral swabs and 12 strains of L. monocytogenes isolated from
vaginal swabs of patients from the Institute for Laboratory Diagnostics "Paster", Belgrade and
Clinic for Gynaecology and Obstetrics “Narodni front”, Belgrade, were included in the further
investigations. The study was approved by the Clinic for Gynaecology and Obstetrics “Narodni
front” Ethical Committee [no. 24/22-2], and all patients signed informed consent form prior
to their inclusion in the study.
Identification of the strains was performed in accordance with standard microbiology
procedures and confirmed by automated Vitek2 System (bioMe´rieux, France). Clinical iso-
lates were stored at -70˚C in brain heart infusion broth (BHI; Lab M Limited, UK) with the
addition of 10% sterile glycerol. Laboratory reference strains S. epidermidis ATCC 12228
and L. monocytogenes ATCC 19111 were used as positive controls. Prior to experiment, bac-
teria (clinical isolates and control strains) were defrosted, inoculated on tryptic soy agar
(TSA; bioMe´rieux) and cultivated in aerobic conditions for 24 h at 35˚C. Further, bacterial
suspensions of grown cultures were prepared in sterile saline (bioMe´rieux) and adjusted to
density of 0.5 McFarland standard (approximately 108 CFU/ml) and then diluted to 106
CFU/ml.
Antimicrobial activity of bacteriocins
The antimicrobial activities spectrum of licheniocin 50.2 and BGBU1-4 crude extract were
tested against clinical isolates and control strains of CoNS and L. monocytogenes with standard
broth-microdilution test in accordance with Clinical Laboratory Standards Institute guidelines
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[19]. In short, serial dilutions of bacteriocins were prepared in fresh Mueller-Hinton broth
(bioMe´rieux) with the addition of 0.05% triphenyl tetrazolium chloride (Sigma-Aldrich) as a
growth indicator, set in triplicate and inoculated with 5x105 CFU/mL of bacteria. Minimal
inhibitory concentrations (MIC) were determined after incubation for 24 h at 35˚C in aerobic
conditions. Each test was repeated three times. The antimicrobial activity was expressed as
arbitrary units (AU) per millilitre. AU is defined as reciprocal of the highest serial twofold dilu-
tion showing growth inhibition of the target strains [20].
Effects of subinhibitory concentrations of licheniocin 50.2 and BGBU1-4
crude extract on biofilm formation by CoNS and L. monocytogenes
strains
Biofilm formation was conducted in 96-well microtiter plates in accordance with Stepanović
et al. [21]. Serial dilutions (1/2 × to 1/32 ×MIC) of licheniocin 50.2 and BGBU1-4 crude
extract were prepared in fresh tryptic soy broth (TSB; bioMe´rieux) supplemented with 1%
glucose (for CoNS) or brain heart infusion broth (BHI; Lab M Limited, UK) supplemented
with 2% glucose and 2% saccharose (for L. monocytogenes). A 180 μL of each dilution was
poured in triplicates into microtiter plate and aliquots (20 μL) of bacterial suspension were
added to each well. Positive controls of each strain (bacteria in medium without presence of
bacteriocins) were incubated under the same conditions. Negative controls for each plate
were growth medium with or without bacteriocins. After 24 h of incubation at 35˚C in aerobic
conditions plates were decanted and rinsed gently three times with 300 μL of sterile phos-
phate-buffered saline (PBS; pH 7.2) to remove planktonic bacterial cells. After air drying
plates were fixed with 150 μL methanol per well for 20 min, dried and stained with 150 μL
(per well) of 2% crystal violet (bioMe´rieux) for 15 min. Unbound dye was rinsed with water.
After air drying dye bound to the biofilm was released with 150 μL of 96% ethanol/well for 20
min. Optical density (OD) was measured at 570 nm using a microtiter plate reader (ICN Flow
Titertek Multiscan Plus) following the calculation of the results according to Stepanović et al.
[21]. Each assay was repeated three times. OD value of negative control (medium with bacte-
riocins) was subtracted from measured OD values of all tested strains and mean OD values
from three experiments were calculated.
To calculate the category of biofilm formation, the cut-off optical density (ODc) was deter-
mined as three standard deviations above the mean OD of the negative control. According to
the obtained results all tested strains were divided into four groups: ODODc—category
0 (no biofilm producer); ODc< OD 2×ODc—category 1 (weak biofilm producer, +);
2×ODc< OD 4×ODc—category 2 (moderate biofilm producer, ++); 4×ODc< OD—cate-
gory 3 (strong biofilm producer, +++).
Effects of licheniocin 50.2 and BGBU1-4 crude extract on formed biofilm
by CoNS and L. monocytogenes
To investigate the effects of licheniocin 50.2 and BGBU1-4 crude extract on formed biofilms,
bacteria were cultivated in TSB or BHI medium in 96-well microtiter plates as previously
described. After 24 h of incubation at 35˚C in aerobic conditions plates were decanted and
rinsed gently three times with 300 μL of sterile PBS. Subsequently, 24 h old biofilms were
exposed to 100 AU/ml and 200 AU/ml of licheniocin 50.2 and BGBU1-4 crude extract (200 μl/
well). Plates were incubated for additional 24 h at 35˚C in aerobic conditions, rinsed, fixed and
dyed as previously described, and the category of formed biofilm was calculated.
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Statistical analysis
The data obtained in this study were analysed in SPSS statistical program (PASW statistics for
Windows, Version 18.0, Chicago: SPSS Inc. USA) using methods of descriptive statistics, Chi
square test and Mann-Whitney U test.
Results
Biochemical characteristics and antimicrobial activity of bacteriocins
Biochemical characteristics of licheniocin 50.2 were previously described [15]. Both bacterio-
cins were active in a broad pH range (2–12), sensitive to different protelytic enzymes and heat
stable.
The activities of licheniocin 50.2 and BGBU1-4 crude extract on planktonic cells of CoNS
and L. monocytogens strains are presented in Table 1. Analysed bacteriocins inhibited the
growth of both CoNS and L. monocytogenes, and the minimal inhibitory concentrations (MIC)
were in the range between 200 and 400 AU/ml for licheniocin 50.2 and between 400 and 3200
AU/ml for BGBU1-4 crude extract. In addition, BGBU1-4 crude extract showed greater anti-
microbial activity on L. monocytogenes strains than on CoNS.
Biofilm formation by CoNS and L. monocytogenes strains
The evaluation of biofilm formation by CoNS and L. monocytogenes clinical isolates and con-
trol strains analysed in the study is presented in Table 1. All tested CoNS and L. monocytogenes
clinical strains possess the ability to form biofilm: 4 (50%) strains of CoNS and 3 (25%) strains
of L. monocytogenes were moderate biofilm producers, 4 (50%) strains of CoNS and 8 strains
(66.7%) of L. monocytogenes were strong biofilm producers. Control strain S. epidermidis
ATCC 12228 belongs to the category of strong and L. monocytogenes ATCC 19111 to the cate-
gory of moderate biofilm producers. The presented OD values of analysed strains illustrated
the individual variability of biofilm density between different isolates of bacteria belonging to
the same species and same biofilm production category (Table 1).
Effects of subinhibitory concentrations of licheniocin 50.2 and BGBU1-4
crude extract on biofilm formation by CoNS and L. monocytogenes
strains
The effects of subinhibitory concentrations of licheniocin 50.2 and BGBU1-4 crude extract on
biofilm formation by CoNS and L. monocytogenes strains were examined in five concentrations
(1/2 × to 1/32 × MIC) and presented in Figs 1 and 2. Significant activity of licheniocin 50.2 on
biofilm formation by CoNS was obtained in 1/2 × and 1/4 × MIC concentrations (p< 0.05,
respectively; Fig 1). All tested subinhibitory concentrations of licheniocin 50.2 had no signifi-
cant inhibitory effects on biofilm formation by L. monocytogenes strains (p> 0.05; Fig 2a). Sig-
nificant activity of BGBU1-4 crude extract on biofilm formation by L. monocytogenes was
obtained in 1/2 × and 1/4 × MIC concentrations (p < 0.01, p< 0.05, respectively, Fig 2b).
When concentration of 1/2 × MIC was used biofilm formation in 7.7% of L. monocytogenes
strains (weak biofilm producers), 23.0% of strains (moderate biofilm producers) and 15.4% of
strains (strong biofilm producers) was completely prevented. The effect of 1/4 × MIC dilution
of BGBU1-4 crude extract was as following: 4 strains (30.8%) reduced biofilm production
from moderate to weak, 3 strains (23.1%) from strong to weak and 2 strains (15.3%) from
strong to moderate biofilm production (p< 0.05). Lower applied concentrations of BGBU1-4
crude extract had no effects on biofilm formation of L. monocytogenes and of CoNS strains
compared to the positive control (p> 0.05; Figs 1 and 2).
Effects of Bacteriocins on Biofilms of Coagulase Negative Staphylococci and Listeria monocytogenes
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Effects of licheniocin 50.2 and BGBU1-4 crude extract on formed biofilm
by CoNS and L. monocytogenes strains
The effects of both bacteriocins were tested in two concentrations (100 AU/mL and 200
AU/mL) on CoNS and L. monocytogenes formed biofilms. Both licheniocin 50.2 and
bacteriocin BGBU1-4 crude extract were found to significantly contribute to eradication
of 24 h old biofilms. Cultivation of 24 h old biofilm with 100 AU/mL and 200 AU/mL
of licheniocin 50.2 significantly reduced the amount of formed biofilm by all tested
strains of CoNS (p<0.01 and p<0.05, respectively). Similar effect was observed after cultiva-
tion of licheniocin 50.2 with formed biofilm of L. monocytogenes strains, with significant
reduction of biofilm amount at concentrations of 100 AU/mL (p<0.001) and 200 AU/mL
(p<0.01).
BGBU1-4 crude extract in concentration of 100 AU/mL and 200 AU/mL significantly
reduced the amount of formed biofilm by all tested strains of CoNS (p<0.01, respectively) and
all tested strains of L. monocytogenes (p<0.001 and p<0.01, respectively). In the presence of
100 AU/ml of BGBU1-4 crude extract, formed biofilm was completely eradicated in all (100%)
S. epidermidis and S. hominis strains and in 76.9% of L. monocytogenes strains. Lower applied
Table 1. Minimal inhibitory concentrations of licheniocin 50.2 and BGBU1-4 crude extract and category of biofilm formation by coagulase negative
staphylococci and Listeria monocytogenes clinical isolates.
Strain Origin of the strain MIC licheniocin 50.2
(AU/ml)






S. epidermidis urethral swab 200 200 2 0.25±0.04
S. epidermidis urethral swab 200 200 3 0.62±0.04
S. epidermidis urethral swab 200 200 2 0.23±0.06
S. epidermidis urethral swab 200 200 3 0.62±0.07
S. haemolyticus urethral swab 400 200 3 0.63±0.30
S. hominis urethral swab 400 200 2 0.28±0.08
S. hominis urethral swab 400 200 3 0.41±0.07
S. lugdunensis urethral swab 400 200 2 0.20±0.02
L. monocytogenes vaginal swab 400 3200 1 0.25±0.03
L. monocytogenes vaginal swab 400 3200 3 1.03±0.09
L. monocytogenes vaginal swab 400 3200 3 0.97±0.06
L. monocytogenes vaginal swab 400 3200 2 0.55±0.02
L. monocytogenes vaginal swab 400 3200 2 0.29±0.04
L. monocytogenes vaginal swab 400 3200 2 0.36±0.01
L. monocytogenes vaginal swab 400 3200 3 0.38±0.01
L. monocytogenes vaginal swab 400 3200 3 1.13±0.07
L. monocytogenes vaginal swab 400 3200 3 0.79±0.04
L. monocytogenes vaginal swab 400 3200 3 0.59±0.03
L. monocytogenes vaginal swab 400 3200 3 0.68±0.04
L. monocytogenes vaginal swab 400 3200 3 1.11±0.08
S. epidermidis ATCC 12228 laboratory control
strain





400 3200 2 0.25±0.02
MIC, minimal inhibitory concentration; AU, arbitrary units; OD, optical density; SD, standard deviation; 1, weak biofilm producer; 2, moderate biofilm
producer; 3, strong biofilm producer.
doi:10.1371/journal.pone.0167995.t001
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concentration of BGBU1-4 crude extract (200 AU/ml) completely eradicated formed biofilm
in 50% of S. epidermidis and S. hominis strains and in 38.5% of L. monocytogenes strains. In
both tested concentrations of BGBU1-4 crude extract, there were no significant differences
(p>0.05) in eradication effects on formed biofilm between CoNS and L. monocytogenes
strains.
Fig 1. The effect of lichenocin 50.2 and BGBU1-4 crude extract on biofilm formation of coagulase negative staphylococci. The effect of
subinhibitory concentrations (1/2–1/32 X MIC) of lichenocin 50.2 and BGBU1-4 crude extract on biofilm formation of S. epidermidis, S. hominis, S.
haemolyticus and S. lugdunensis. Results are presented as mean OD ± standard deviation; Category ++, moderate biofilm producer; Category +++,
strong biofilm producer; * p<0.05. Control–biofilm density of bacteria cultivated in medium without presence of bacteriocins.
doi:10.1371/journal.pone.0167995.g001
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Discussion
In the last few decades, the exploration of new bacteriocins with enhanced biochemical fea-
tures and broad antimicrobial activity has gained significance. In the present study, bacteriocin
licheniocin 50.2 from B. licheniformis VPS50.2 and BGBU1-4 crude extract were investigated.
Our previous work on these novel bacteriocins demonstrated that, due to their biochemical
properties, they can be classified as class II bacteriocins. In order for it to be applied in different
fields, it is important to be familiar with the mechanism of bacteriocins activity. So far five dif-
ferent target molecules involved in this have been identified [22]. Licheniocin 50.2 was not
active against Lactococcus lactis ssp. lactis strain B464, derivative of IL1403 (man-PTS deletion
Fig 2. The effect of lichenocin 50.2 and BGBU1-4 crude extract on biofilm formation of L. Monocytogenes. The
effect of subinhibitory concentrations (1/2–1/256 X MIC) of lichenocin 50.2 (2a) and BGBU1-4 crude extract (2b) on biofilm
formation of L. monocytogenes. Results are presented as mean OD ± standard deviation; Category +, weak biofilm
producer; Category ++, moderate biofilm producer; Category +++, strong biofilm producer; * p<0.05, ** p<0.01. Control–
biofilm density of bacteria cultivated in medium without presence of bacteriocins.
doi:10.1371/journal.pone.0167995.g002
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mutant) suggesting that man-PTS is a receptor for activity of this bacteriocin [15]. Other class
II bacteriocins, such as pediocin-like bacteriocin and lactococcin A employ man-PTS as a
receptor [23,24]. However, preliminary tests showed that bacteriocin BGBU1-4 was active
against B464, revealing that man-PTS is not a receptor for this bacteriocin (data not shown). It
is known that class II bacteriocins have high bactericidal activities against many Gram-positive
and Gram-negative bacteria, including CoNS and L. monocytogenes strains [14,25]. In the pres-
ent study, the susceptibilities of the various staphylococcal species were diverse, especially to
licheniocin 50.2. While S. epidermidis showed MIC values of 200 AU/ml for licheniocin 50.2,
some other staphylococcal species, such as nonpathogenic S. hominis, S. haemolyticus or S. lug-
dunensis, were more susceptible. On the other hand, both bacteriocins demonstrate better anti-
microbial activity on L. monocytogenes strains. It is well known that CoNS are more resistant
to conventional antimicrobial agents compared to L. monocytogenes strains. However, in this
study, CoNS were still sufficiently susceptible to consider licheniocin 50.2 and BGBU1-4 crude
extract as a potential antimicrobial therapeutic agent.
At present, researches based on possible application of bacteriocins in medicine are of
continuous interest. So far, there have been few reports on possible genital application of bac-
teriocins, for example effects of vaginal probiotics and their bacteriocins were evaluated on
bacterial strains of non-genital origin [26], and so on. The vagina is subject to many distur-
bances which can result in vaginal pH value changes [27]. Bacterial vaginosis and aerobic vagi-
nitis, two most common causes of abnormal vaginal discharge which are often mixed with
other infections (bacterial infections, vulvovaginal candidiasis, Trichomonas vaginalis) are
characterised by pH value 4,5 [28]. The administration of bacteriocins active in a broad pH
range can be important for the treatment of vaginal infections and for maintaining a normal
urogenital health. Furthermore, prior studies emphasised the possible role of CoNS on repro-
ductive health of both men and women. CoNS are commonly isolated in patients with aerobic
vaginitis and nonspecific urethritis [1,2]. Moreover, it has been shown that the contact of these
bacteria with ejaculated spermatozoa can be a reason for severe injury of sperm membrane sta-
bility and mitochondrial activity with potential consequences on male fertility [29]. Addition-
ally, L. monocytogenes can colonise genital tract and grow when there is an increase in pH [3]
and in cases of pregnant women cause miscarriage, stillbirth, preterm labour and neonatal
infections.
The main goal of this study was to evaluate activity of two novel bacteriocins against formed
biofilms and biofilm formation. Biofilm-asocciated infections substantially affect human
health, making them challenging to combat due to their antimicrobial resistance [5–7]. Hence,
the prevention of biofilms is of utmost importance for modern medicine. The fact is that sub-
inhibitory concentration of various antimicrobial agents possesses inhibitory effects on biofilm
formation by different microorganisms [30,31]. On the other hand, it has also been reported
that subinhibitory concentrations of some antimicrobial agents even enhance biofilm forma-
tion, for example erythromycin, nafcillin, quinupristin-dalfopristin, tetracycline and vancomy-
cin on staphylococcal biofilm formation [32]. In our study, significant inhibition of biofilm
formation was detected at 1/2 × and 1/4 × MIC for licheniocin 50.2 on CoNS and 1/2 × and 1/
4 × MIC for BGBU1-4 crude extract on L. monocytogenes, suggesting that biofilm-relevant
functions were affected at subinhibitory concentrations of both bacteriocins. This result indi-
cated that licheniocin 50.2 and BGBU1-4 crude extract already exert an inhibiting effect on
biofilm formation before they inhibit growth of CoNS and L. monocytogenes, respectively. Ear-
lier studies showed that class I and class II bacteriocins inhibit transcription of genes involved
in adherence and production of extracellular polymeric substances by staphylococci [32,33],
implying it to be antibiofilm mechanism of licheniocin 50.2 and BGBU1-4 crude extract. Addi-
tionally, although licheniocin 50.2 showed similar activity on planktonic cells of CoNS and L.
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monocytogenes, subinhibitory concentration of this bacteriocin only affected staphylococcal
biofilm formation. One hypothesis for this result could be the effect of dose or evidence of
existence of different targets for bacteriocin action in biofilm formation process for various
bacteria.
Once a biofilm has been established, the bacterial cells are extremely robust against all
kinds of antimicrobial agents. Therefore, we studied the antibiofilm effects of licheniocin 50.2
and BGBU1-4 crude extract on 24 h old biofilms. Since the aim of the study was evaluation of
possible genital application of these bacteriocins, two concentrations (100 AU/ml and 200 AU/
ml) were analysed. Significant effects were seen with tested concentrations of licheniocin 50.2
and BGBU1-4 crude extract on formed biofilm of CoNS and L. monocytogenes strains. More-
over, these bacteriocins have an impact on formed biofilm of both bacteria, compared to the
effects of subinhibitory concentration of bacteriocins where licheniocin 50.2 was active only
on biofilm formation by CoNS and BGBU1-4 crude extract on biofilm formation by L. mono-
cytogenes. Obtained results suggest that biofilm destruction by the bacteriocins was due not
only to bacteria killing but also to destruction of the extracellular matrix and clearing of the
biofilms from the surface.
Conclusions
In conclusion, this study suggests that novel class II bacteriocins, licheniocin 50.2 and bacterio-
cins from BGBU1-4 crude extract, have potential to be used for genital application, to prevent
biofilm formation and/or to eradicate biofilm formed by CoNS and L. monocytogenes strains
in genital tract and consequently to reduce genital and neonatal infections. Further studies are
in progress to evaluate the possible effects of these bacteriocins on other genital bacteria and
their biofilms. Also, for future research, some mode of application and in vivo testing should
take place.
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